Cargando…

Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3

Chlorinated gymnastatin and dankastatin alkaloids derived from the fungal strain Gymnascella dankaliensis have been reported to possess significant anti-cancer activity but their mode of action is unknown. These members possess electrophilic functional groups that may undergo covalent bond formation...

Descripción completa

Detalles Bibliográficos
Autores principales: Belcher, Bridget P., Machicao, Paulo A., Tong, Binqi, Ho, Emily, Friedli, Julia, So, Brian, Bui, Helen, Isobe, Yosuke, Maimone, Thomas J., Nomura, Daniel K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934694/
https://www.ncbi.nlm.nih.gov/pubmed/36798342
http://dx.doi.org/10.1101/2023.02.11.528139
_version_ 1784889931025350656
author Belcher, Bridget P.
Machicao, Paulo A.
Tong, Binqi
Ho, Emily
Friedli, Julia
So, Brian
Bui, Helen
Isobe, Yosuke
Maimone, Thomas J.
Nomura, Daniel K.
author_facet Belcher, Bridget P.
Machicao, Paulo A.
Tong, Binqi
Ho, Emily
Friedli, Julia
So, Brian
Bui, Helen
Isobe, Yosuke
Maimone, Thomas J.
Nomura, Daniel K.
author_sort Belcher, Bridget P.
collection PubMed
description Chlorinated gymnastatin and dankastatin alkaloids derived from the fungal strain Gymnascella dankaliensis have been reported to possess significant anti-cancer activity but their mode of action is unknown. These members possess electrophilic functional groups that may undergo covalent bond formation with specific proteins to exert their biological activity. To better understand the mechanism of action of this class of natural products, we mapped the proteome-wide cysteine-reactivity of the most potent of these alkaloids, dankastatin B, using activity-based protein profiling chemoproteomic approaches. We identified a primary target of dankastatin B in breast cancer cells as cysteine C65 of the voltage-dependent anion selective channel on the outer mitochondrial membrane VDAC3. We demonstrated direct and covalent interaction of dankastatin B with VDAC3. VDAC3 knockdown conferred hyper-sensitivity to dankastatin B-mediated anti-proliferative effects in breast cancer cells indicating that VDAC3 was at least partially involved in the anti-cancer effects of this natural product. Our study reveals a potential mode of action of dankastatin B through covalent targeting of VDAC3 and highlight the utility of chemoproteomic approaches in gaining mechanistic understanding of electrophilic natural products.
format Online
Article
Text
id pubmed-9934694
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-99346942023-02-17 Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3 Belcher, Bridget P. Machicao, Paulo A. Tong, Binqi Ho, Emily Friedli, Julia So, Brian Bui, Helen Isobe, Yosuke Maimone, Thomas J. Nomura, Daniel K. bioRxiv Article Chlorinated gymnastatin and dankastatin alkaloids derived from the fungal strain Gymnascella dankaliensis have been reported to possess significant anti-cancer activity but their mode of action is unknown. These members possess electrophilic functional groups that may undergo covalent bond formation with specific proteins to exert their biological activity. To better understand the mechanism of action of this class of natural products, we mapped the proteome-wide cysteine-reactivity of the most potent of these alkaloids, dankastatin B, using activity-based protein profiling chemoproteomic approaches. We identified a primary target of dankastatin B in breast cancer cells as cysteine C65 of the voltage-dependent anion selective channel on the outer mitochondrial membrane VDAC3. We demonstrated direct and covalent interaction of dankastatin B with VDAC3. VDAC3 knockdown conferred hyper-sensitivity to dankastatin B-mediated anti-proliferative effects in breast cancer cells indicating that VDAC3 was at least partially involved in the anti-cancer effects of this natural product. Our study reveals a potential mode of action of dankastatin B through covalent targeting of VDAC3 and highlight the utility of chemoproteomic approaches in gaining mechanistic understanding of electrophilic natural products. Cold Spring Harbor Laboratory 2023-02-11 /pmc/articles/PMC9934694/ /pubmed/36798342 http://dx.doi.org/10.1101/2023.02.11.528139 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Belcher, Bridget P.
Machicao, Paulo A.
Tong, Binqi
Ho, Emily
Friedli, Julia
So, Brian
Bui, Helen
Isobe, Yosuke
Maimone, Thomas J.
Nomura, Daniel K.
Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3
title Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3
title_full Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3
title_fullStr Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3
title_full_unstemmed Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3
title_short Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3
title_sort chemoproteomic profiling reveals that anti-cancer natural product dankastatin b covalently targets mitochondrial vdac3
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934694/
https://www.ncbi.nlm.nih.gov/pubmed/36798342
http://dx.doi.org/10.1101/2023.02.11.528139
work_keys_str_mv AT belcherbridgetp chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3
AT machicaopauloa chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3
AT tongbinqi chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3
AT hoemily chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3
AT friedlijulia chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3
AT sobrian chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3
AT buihelen chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3
AT isobeyosuke chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3
AT maimonethomasj chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3
AT nomuradanielk chemoproteomicprofilingrevealsthatanticancernaturalproductdankastatinbcovalentlytargetsmitochondrialvdac3